OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression
Jingjing Cong, Xianwei Wang, Xiaohu Zheng, et al.
Cell Metabolism (2018) Vol. 28, Iss. 2, pp. 243-255.e5
Open Access | Times Cited: 293

Showing 26-50 of 293 citing articles:

Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 8

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 6

Targeting KRAS: from metabolic regulation to cancer treatment
Yanyan Shi, Huiling Zheng, Tianzhen Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 5

NK Cell Dysfunction and Checkpoint Immunotherapy
Jiacheng Bi, Zhigang Tian
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 134

Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
Luana Guerra, Lynn Bonetti, Dirk Brenner
Cell Reports (2020) Vol. 32, Iss. 1, pp. 107848-107848
Open Access | Times Cited: 133

Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer
Jiangang Zhao, Hans Schlößer, Zhefang Wang, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 874-874
Open Access | Times Cited: 119

What Defines NK Cell Functional Fate: Phenotype or Metabolism?
Sophie M. Poznanski, Ali A. Ashkar
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 119

Transformable Honeycomb‐Like Nanoassemblies of Carbon Dots for Regulated Multisite Delivery and Enhanced Antitumor Chemoimmunotherapy
Lin Hou, Dandan Chen, Ruiting Wang, et al.
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 12, pp. 6581-6592
Closed Access | Times Cited: 114

Natural Killer Cells in the Lungs
Jingjing Cong, Haiming Wei
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 110

Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
Jules Russick, Pierre-Emmanuel Joubert, Mélanie Gillard-Bocquet, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001054-e001054
Open Access | Times Cited: 79

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
Cai Zhang, Yuxia Liu
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 76

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
Xin Lian, Kailin Yang, Renliang Li, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 70

Immune cell metabolism and metabolic reprogramming
Chenchen Hu, Yuxin Xuan, Xiyang Zhang, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 9783-9795
Open Access | Times Cited: 66

NK Cell Therapy: A Rising Star in Cancer Treatment
Nawen Du, Feifei Guo, Yufeng Wang, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4129-4129
Open Access | Times Cited: 60

Metabolic changes of Interleukin-12/15/18-stimulated human NK cells
Iñigo Terrén, Ane Orrantia, Alba Mosteiro, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 59

Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis
Mingrui Zhu, Yi Huang, Matthew E. Bender, et al.
Cancer Research (2021) Vol. 81, Iss. 7, pp. 1813-1826
Open Access | Times Cited: 57

Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure
Zhen‐Zhen Lai, Yun Wang, Wen‐Jie Zhou, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6527-6547
Open Access | Times Cited: 55

Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands
Jian Zhong, Xuesong Yang, Junju Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46

NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
Xiaowei Guo, Siyu Tan, Tixiao Wang, et al.
Hepatology (2022) Vol. 78, Iss. 2, pp. 468-485
Closed Access | Times Cited: 40

Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment
Mengyao Jin, Wei Cao, Bo Chen, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 39

NK cell exhaustion in the tumor microenvironment
Jia Hao, Hongmei Yang, Huaxing Xiong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38

Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy
Lizhen He, Jianfu Zhao, Hongjun Li, et al.
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 28

Natural killer cells and type 1 innate lymphoid cells in cancer
Noëlla Lopes, Éric Vivier, Émilie Narni-Mancinelli
Seminars in Immunology (2023) Vol. 66, pp. 101709-101709
Open Access | Times Cited: 27

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Haixia Zhang, Shizhen Li, Dan Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 16

Immunosurveillance encounters cancer metabolism
Yu‐Ming Chuang, Sheue‐Fen Tzeng, Ping‐Chih Ho, et al.
EMBO Reports (2024) Vol. 25, Iss. 2, pp. 471-488
Open Access | Times Cited: 15

Scroll to top